Gene G. Kinney

6.3k citations

89 papers · 4.5k indexed · h-index 36

Cellular and Molecular Neuroscience top 0.5%
Molecular Biology top 5%
Physiology top 1%
Cognitive Neuroscience top 2%
Neurology top 2%

Co-authors: P. Jeffrey Conn Cyrille Sur Bernát Kocsis Robert P. Vertes Maryann Burno Paul J. Shughrue David L. Williams Craig W. Lindsley
Topics: Neuroscience and Neuropharmacology Research (32 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers)Alzheimer's disease research and treatments (21 papers)
Cited by: Cellular and Molecular Neuroscience Biological Psychiatry Physiology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Clinical Oncology
Partner nations: United States Italy Germany

In The Last Decade

Gene G. Kinney

86 papers receiving 4.4k citations

Peers

Countries citing papers authored by Gene G. Kinney

Since Specialization

Citations

This map shows the geographic impact of Gene G. Kinney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene G. Kinney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene G. Kinney more than expected).

Fields of papers citing papers by Gene G. Kinney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene G. Kinney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene G. Kinney. The network helps show where Gene G. Kinney may publish in the future.

Co-authorship network of co-authors of Gene G. Kinney

This figure shows the co-authorship network connecting the top 25 collaborators of Gene G. Kinney. A scholar is included among the top collaborators of Gene G. Kinney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene G. Kinney. Gene G. Kinney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PRX005, a novel anti‐MTBR tau monoclonal antibody: results from a first‐in‐human double‐blind, placebo‐controlled, single ascending dose phase 1 study 2023 ·Alzheimer s & Dementia ·Ferenc Martényi,Brian Campbell,Gene G. Kinney,Jun Lee,Yuying Jin,Wagner Zago,Hideki Garren	4
2	P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES 2023 ·HemaSphere ·Morie A. Gertz,Adam D. Cohen,Raymond L. Comenzo,Efstathios Kastritis,Heather Landau,Edward N. Libby,Michaela Liedtke,Vaishali Sanchorawala,Stefan Schönland,Ashutosh Wechalekar,Yukio Ando,Youngil Koh,Jeffrey A. Zonder,Giovanni Palladini,(unknown),Carol L. Karp,(unknown),Anne Conrad,Gene G. Kinney,Giampaolo Merlini	1
3	Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design 2021 ·Blood ·Morie A. Gertz,(unknown),Gene G. Kinney	6
4	First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction 2016 ·Journal of Clinical Oncology ·Morie A. Gertz,Heather Landau,Raymond L. Comenzo,David C. Seldin,Brendan M. Weiss,Jeffrey A. Zonder,Giampaolo Merlini,Stefan Schönland,Jackie Walling,Gene G. Kinney,Martin Koller,Dale B. Schenk,Spencer Guthrie,Michaela Liedtke	147
5	NEOD001 DEMONSTRATES CARDIAC AND RENAL BIOMARKER RESPONSES IN A PHASE 1/2 STUDY IN PATIENTS WITH AMYLOID LIGHT CHAIN AMYLOIDOSIS AND PERSISTENT ORGAN DYSFUNCTION 2016 ·Journal of the American College of Cardiology ·Michaela Liedtke,Raymond L. Comenzo,Heather Landau,David C. Seldin,Brendan M. Weiss,Jeffrey A. Zonder,Jackie Walling,Gene G. Kinney,Martin Koller,Morie A. Gertz	1
6	Emerging drug targets in amyotrophic lateral sclerosis 2012 ·Expert Opinion on Orphan Drugs ·Michael P. Bova,Gene G. Kinney	4
7	Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice 2012 ·Experimental Neurology ·Frédérique Bard,Michael Fox,Stuart Friedrich,Peter Seubert,Dale Schenk,Gene G. Kinney,Ted Yednock	40
8	Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound 2010 ·Journal of Neuroscience ·Jacquelynn J. Cook,Kristin R. Wildsmith,(unknown),Marie A. Holahan,Gene G. Kinney,Parker D. Mathers,Maria S. Michener,Eric A. Price,Mark S. Shearman,Adam J. Simon,(unknown),Guoxin Wu,Kevin E. Yarasheski,Randall J. Bateman	60
9	Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zhijian Zhao,William Leister,Julie A. O’Brien,Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,George D. Hartman,Craig W. Lindsley,S. E. Wolkenberg	16
10	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties 2009 ·Bioorganic & Medicinal Chemistry Letters ·S. E. Wolkenberg,Zhijian Zhao,David D. Wisnoski,William Leister,(unknown),Wei Lemaire,David L. Williams,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,D. J. PETTIBONE,Philip R. Tiller,Sheri Smith,Christopher R. Gibson,Bennett Ma,(unknown),Craig W. Lindsley,George D. Hartman	15
11	Design, Synthesis, and In Vivo Efficacy of Glycine Transporter‐1 (GlyT1) Inhibitors Derived from a Series of [4‐Phenyl‐1‐(propylsulfonyl)piperidin‐4‐yl]methyl Benzamides 2006 ·ChemMedChem ·Craig W. Lindsley,Zhijian Zhao,William Leister,(unknown),Wei Lemaire,David L. Williams,Tsing‐Bau Chen,Raymond S.L. Chang,Maryann Burno,Marlene A. Jacobson,Cyrille Sur,Gene G. Kinney,Douglas J. Pettibone,Philip R. Tiller,Sheri Smith,Nancy N. Tsou,Mark E. Duggan,P. Jeffrey Conn,George D. Hartman	32
12	The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease 2006 ·Current Topics in Medicinal Chemistry ·Susan M. Catalano,Elizabeth A. Dodson,Darrell A. Henze,Joseph G. Joyce,Grant A. Krafft,Gene G. Kinney	88
13	The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats 2004 ·Psychopharmacology ·Una C. Campbell,(unknown),Lisa M. Hernández,Gene G. Kinney,P. Jeffrey Conn,Linda J. Bristow	97
14	Ontogeny of REM sleep in ratspossible implications for endogenous depression 2000 ·Physiology & Behavior ·G Vogel,Pingfa Feng,Gene G. Kinney	48
15	Brainstem carbachol injections in the urethane anesthetized rat produce hippocampal theta rhythm and cortical desynchronization: a comparison of pedunculopontine tegmental versus nucleus pontis oralis injections 1998 ·Brain Research ·Gene G. Kinney,Gerald W. Vogel,Pingfu Feng	44
16	Medial septal unit firing characteristics following injections of 8-OH-DPAT into the median raphe nucleus 1996 ·Brain Research ·Gene G. Kinney,Bernát Kocsis,Robert P. Vertes	49
17	The supramammillary nucleus: Is it necessary for the mediation of hippocampal theta rhythm? 1995 ·Neuroscience ·Jeffrey S. Thinschmidt,Gene G. Kinney,Bernát Kocsis	81
18	Injections of muscimol into the median raphe nucleus produce hippocampal theta rhythm in the urethane anesthetized rat 1995 ·Psychopharmacology ·Gene G. Kinney,Bernát Kocsis,Robert P. Vertes	51
19	Separation of hippocampal theta dipoles by partial coherence analysis in the rat 1994 ·Brain Research ·Bernát Kocsis,Jeffrey S. Thinschmidt,Gene G. Kinney,Robert P. Vertes	11
20	Pharmacological suppression of the median raphe nucleus with serotonin1a agonists, 8-OH-DPAT and buspirone, produces hippocampal theta rhythm in the rat 1994 ·Neuroscience ·Robert P. Vertes,Gene G. Kinney,Bernát Kocsis,(unknown)	87

About Gene G. Kinney

Gene G. Kinney is a scholar working on Cellular and Molecular Neuroscience, Physiology and Biochemistry, having authored 89 papers that have together received 4.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (32 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (22 papers) and Alzheimer's disease research and treatments (21 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.4k citations), Biological Psychiatry (240 citations) and Physiology (1.4k citations). Gene G. Kinney has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include P. Jeffrey Conn, Cyrille Sur, Bernát Kocsis, Robert P. Vertes, Maryann Burno, Paul J. Shughrue, David L. Williams, Craig W. Lindsley, Wagner Zago and Michael Grundman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact